Zynerba Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€29.89M -7.4% N/A -€19.64M -31.5% N/A
    €0.00 +NaN% -€32.28M -25.4% N/A -€28.68M -18.3% N/A
    €0.00 +NaN% -€43.27M +60.4% N/A -€35.08M +17.8% N/A
    €0.00 -100.0% -€26.98M -21.2% N/A -€29.78M +8.0% N/A
    €73.83K +1,086.2% -€34.26M +24.7% -46,408.3% +4.0K pp -€27.57M +24.8% -37,338.0% +3.2K pp
    €6.22K +0.0% -€27.48M +36.9% -441,549.0% -1.2K pp -€22.09M +26.6% -354,856.5% -740 pp
    €6.22K -97.4% -€20.08M +86.3% -322,600.1% -3.2K pp -€17.45M +112.4% -280,393.6% -2.8K pp
    €239.42K -65.6% -€10.77M +121.4% -4,500.3% -38 pp -€8.22M +171.8% -3,431.5% -30 pp
    €695.35K -14.2% -€4.87M +790.3% -699.9% -6.3 pp -€3.02M +2,961.6% -434.7% -4.2 pp
    €810.29K -€546.65K -67.5% -€98.73K -12.2%

    Notifications